Medical Writing Non-Clinical Health Writing Nanoapplications – From geckos to human health
mew-150pxjpg

Volume 23, Issue 3 - Non-Clinical Health Writing

Nanoapplications – From geckos to human health

Abstract

Nanotechnology, the manipulation of matter on a molecular scale, is all around us in our everyday lives. Chocolate, non-dairy creamer, and sunscreen are examples of consumer products with a high content of nanoparticles. Nanotechnology holds great potential for environmental applications like wastewater treatment and nanobionic engineering of plants. Due to their unique and adaptable properties for targeted therapeutic payload delivery, nanoparticles are also emerging as promising tools for innovative pharmaceutical treatment. Nevertheless, licensing regulations specifically for nanomaterials are lacking, and the long-term effects of nanoparticles on both the environment and human health need to be further clarified.

Download the full article

References

  1. Ge L, Sethi S, Ci L, Ajayan PM, Dhinojwala A. Carbon nanotube-based synthetic gecko tapes. Proc Natl Acad Sci USA 2007;104(26):10792–5.
  2. European Commission. Definition of nanomaterials (2011) [cited 2014 Feb 11]. Available from: http://ec.europa.eu/nanotechnology/policies_en.html
  3. Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 2010;7(4):479–95.
  4. Mody VV, Siwale R, Singh A, Mody HR. Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2010;2(4):282–9.
  5. Li W, Zhao M, Ke C, Zhang G, Zhang L, Li H, et al. Nano polymeric carrier fabrication technologies for advanced antitumor therapy. Biomed Res Int 2013;2013:305089.
  6. Han Z, Conley SM, Naash MI. AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci 2011;52(6):3051–9.
  7. Raula J, Lehtimäki M, Karppinen M, Antopolsky M, Jiang H, Rahikkala A, et al. Preparation of amino acid nanoparticles at varying saturation conditions in an aerosol flow reactor. J Nanopart Res 2012;14:986.
  8. Beutner R, Michael J, Schwenzer B, Scharnweber D. Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J R Soc Interface 2010;7(Suppl 1):S93–105.
  9. Laroui H, Geem D, Xiao B, Viennois E, Rakhya P, Denning T, et al. Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles. Mol Ther 2014;22(1):69–80.
  10. Dick K, Dhanasekaran T, Zhang Z, Meisel D. Size-dependent melting of silica-encapsulated gold nanoparticles. J Am Chem Soc 2002;124(10):2312–7.
  11. Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol 2013;24(6):1159–66.
  12. Eustis S, el-Sayed MA. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev 2006;35(3):209–17.
  13. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 2011;44(10):947–56.
  14. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 2012;46(4):2242–50.
  15. Smijs TG, Pavel S. Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness. Nanotechnol Sci Appl 2011;4:95–112.
  16. Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002;61(1):123–30.
  17. Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci 2012;88(3):53–71.
  18. European Medicines Agency. Abraxane® – summary of product characteristics (2014) [cited 2014 Feb 24].
  19. European Medicines Agency. Myocet® – summary of product characteristics (2014) [cited 2014 Feb 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000297/WC500031811.pdf
  20. O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 2004;15(3):440–9.
  21. Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005;23(31):7794–803.
  22. Lerch S, Dass M, Musyanovych A, Landfester K, Mailander V. Polymeric nanoparticles of different sizes overcome the cell membrane barrier. Eur J Pharm Biopharm 2013;84(2):265–74.
  23. Tinkle S, McNeil SE, Muhlebach S, Bawa R, Borchard G, Barenholz YC, et al. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci 2014;1313(1):35–56.
  24. Senjen R. Nanomedicine – new solutions or new problems? (2013) [cited 2014 May 26].
  25. Smita S, Gupta SK, Bartonova A, Dusinska M, Gutleb AC, Rahman Q. Nanoparticles in the environment: assessment using the causal diagram approach. Environ Health 2012;11(Suppl 1):S13.
  26. Qu X, Alvarez PJ, Li Q. Applications of nanotechnology in water and wastewater treatment. Water Res 2013;47(12):3931–46.
  27. Giraldo JP, Landry MP, Faltermeier SM, McNicholas TP, Iverson NM, Boghossian AA, et al. Plant nanobionics approach to augment photosynthesis and biochemical sensing. Nat Mater 2014;13(4):400–8.
  28. Cedervall T, Hansson LA, Lard M, Frohm B, Linse S. Food chain transport of nanoparticles affects behaviour and fat metabolism in fish. PLoS ONE 2012;7(2):e32254.
  29. Rico CM, Majumdar S, Duarte-Gardea M, Peralta-Videa JR, Gardea-Torresdey JL. Interaction of nanoparticles with edible plants and their possible implications in the food chain. J Agric Food Chem 2011;59(8):3485–98.

Search

Articles

Non-clinical health writing
President's Message
EMWA social media team
Opportunities in veterinary writing
Veterinary regulatory writing in Europe
Exploring veterinary science, a little-known translation specialisation
Cosmetic regulatory writing
REACH chemical dossiers? Yes, please!
Pesticide dossiers, an opportunity for medical writers
Nanoapplications – From geckos to human health
Medical writing for in vitro diagnostics: A different approach for the ‘hidden’ side of healthcare
Writing bioanalytical reports
Letter to the Editor: Because you're worth it?
Cost comparison of salaried and freelance medical writers working in Europe
Profile: An interview with Fernando Navarro on the brand new platform ‘Cosnautas’
Key factors a pharmaceutical company should consider while outsourcing medical writing services
Working with authors to develop high-quality, ethical clinical manuscripts: Guidance for the professional medical writer
News from the EMA
The Webscout
English Grammar and Style - Points of view
Medical Communication
In the Bookstores
Out On Our Own
Erratum

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: